**Executive Summary**
This document addresses Unstarred Question No. 1010 regarding the quality of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homoeopathy) medicines and products, to be answered on December 5, 2025. The Ministry of AYUSH provides details on regulatory provisions, quality control measures, research initiatives, and schemes aimed at ensuring the quality and standardization of AYUSH products. No specific action items or deadlines are mentioned.
**Key Points / Main Content**
* **Regulatory Framework:**
* The Drugs & Cosmetics Act, 1940, and Drugs Rules, 1945, have exclusive regulatory provisions for Ayurvedic, Siddha, Sowa Rigpa, Unani, and Homoeopathy drugs.
* Manufacturers must adhere to Good Manufacturing Practices (GMP) and quality standards as per Schedule T & Schedule M-I of Drugs Rules, 1945, and respective pharmacopoeia.
* **Standardization and Quality Control:**
* The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) lays down formulary specifications and pharmacopoeial standards for ASU&H drugs.
* Compliance with quality standards is mandatory for the production of ASU&H drugs.
* PCIM&H acts as the Appellate Drugs testing Laboratory for testing or analysis of ASU&H Drugs.
* Rule 160 A to J of the Drugs Rules, 1945 provides guidelines for approving Drug Testing Laboratories.
* 34 State/UTs Drug Testing Laboratories and 108 private laboratories are approved or licensed for quality testing.
* **Research and Development:**
* Central Councils for Research in Ayurveda, Yoga & Naturopathy, Unani, Siddha & Homoeopathy are apex organizations for research in AYUSH systems.
* AYURGYAN Scheme, implemented from FY 2021-22, supports capacity building, research, and integrated health research in AYUSH.
* Financial assistance is provided to organizations for research studies in the AYUSH system.
* **International Cooperation:**
* The Ministry implements the central sector scheme for Promotion of International Cooperation for Ayush (IC Scheme).
* The Ministry provides support to Indian Ayush drug Manufacturers/ Ayush Service providers to give boost to the export of Ayush products and services, facilitates the International promotion, development and recognition of Ayush systems of medicine, foster interaction of stakeholders and market development of Ayush at international level, promote academics and research through the establishment of Ayush Academic Chairs in foreign countries and holding training workshop/symposiums for promoting and strengthening awareness and interest about Ayush Systems of Medicine at international level.
* 25 Country-to-Country MoUs, 15 Ayush Chair MoUs and 52 Institute-to-Institute level MoUs have been signed under the IC Scheme.
* **Scheme AOGUSY:**
* The Ministry of Ayush has implemented Central Sector Scheme Ayush Oushadhi Gunvatta Evam Uttpadan Samvardhan Yojana (AOGUSY).
* The total financial allocation to this scheme is Rs. 122.00 crores for five years.
* Components include strengthening pharmacies and drug testing laboratories, pharmacovigilance, regulatory framework enhancement, and support for standards development.
* **Certifications:**
* The scheme for Certification of Pharmaceutical Product (CoPP) is extended to ASU medicines.
* The Quality Council of India (QCI) implements a quality certification scheme for Ayush products (Ayush Standard and Ayush Premium).
* **State/UT-Specific Information:**
* Details are provided for specific actions taken by Uttarakhand, Madhya Pradesh, Delhi, Puducherry, Ladakh, Kerala, Tripura, Haryana, Arunachal Pradesh, Uttar Pradesh, Bihar and Odisha.
**Impact Analysis**
**AYUSH Manufacturers**
* **Impact:** Manufacturers need to adhere to quality standards, GMP, and obtain certifications for their products.
* **Action Required:** Comply with regulatory provisions, undergo quality testing, and apply for certifications like CoPP and Ayush mark.
**State/UT Governments**
* **Impact:** State/UT governments need to maintain and enhance drug testing laboratories and regulatory frameworks for AYUSH products.
* **Action Required:** Enforce quality standards, conduct regular inspections, and support the implementation of AYUSH schemes.
**Consumers of AYUSH Products**
* **Impact:** Consumers benefit from improved quality, standardization, and safety of AYUSH medicines and products.
* **Action Required:** Be aware of certified AYUSH products and report any adverse drug reactions.
**Drug Regulatory Authorities and Drug Analysts**
* **Impact:** They will be involved in the standardization, quality control, testing, and analysis of AYUSH drugs.
* **Action Required:** Regularly attend capacity-building training on laboratory techniques and methodologies.
Key Entities Referenced
Ministry of AYUSH: The primary ministry responsible for the development and promotion of AYUSH systems in India.
Drugs & Cosmetics Act, 1940: The principal legislation governing the regulation of drugs and cosmetics, including AYUSH medicines, in India.
Drugs Rules, 1945: Rules formulated under the Drugs and Cosmetics Act, 1940 that provide detailed regulations for the manufacturing, testing, and quality control of drugs, including AYUSH medicines.
AYUSH Oushadhi Gunvatta Evam Uttpadan Samvardhan Yojana (AOGUSY): A central sector scheme implemented by the Ministry of AYUSH to improve the quality and production of AYUSH medicines.
Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H): Subordinate office of Ministry of Ayush which lays down the formulary specifications and pharmacopoeial standards for ASU&H drugs.
GOVERNMENT OF INDIA
MINISTRY OF AYUSH
LOK SABHA
UNSTARRED QUESTION NO. 1010
TO BE ANSWERED ON 05th DECEMBER, 2025
Quality AYUSH Medicines and Products
1010. Shri Janardan Singh Sigriwal:
Will the Minister of AYUSH
be pleased to state:
(a) whether any shortfall has been noticed in manufacturing of various AYUSH medicines
and if so, the details thereof;
(b) whether the Government proposes to formulate any mechanism to address the issue of
standardization and quality control of AYUSH medicines and products in the country;
(c) if so, the details thereof along with the efforts to improve the quality of AYUSH
medicines/products, State/UT-wise, particularly in Bihar;
(d) the measures taken/proposed to be taken to enhance research and development in the field
of AYUSH along with the efforts to collaborate with international organizations; and
(e) the plans of the Government to promote quality AYUSH medicines and products for
wider use by the consumers?
ANSWER
THE MINISTER OF STATE (IC) OF THE MINISTRY OF AYUSH
(SHRI PRATAPRAO JADHAV)
(a) As per the information received from States/ UTs governments, there is no shortfall
noticed in the manufacturing of various Ayush medicines.
(b) and (c) The Drugs & Cosmetics Act, 1940 and Drugs Rules, 1945 have exclusive
regulatory provisions for Ayurvedic, Siddha, Sowa Rigpa, Unani, and Homoeopathy drugs.
Provisions related to Ayurveda, Siddha, Sowa Rigpa and Unani Drugs are contained in
Chapter IVA and Schedule- I of the Drugs and Cosmetics Act, 1940 and Rules 151 to 169,
Schedules E (I), T & TA of the Drugs Rules, 1945. Further, second schedule (4A) of the
Drugs and Cosmetics Act, 1940 provides standards for Homoeopathic drugs and Rules 2dd,
30AA, 67 (C-H), 85 (A to I), 106-A, Schedule K, Schedule M-I of the Drugs Rules, 1945
pertain to Homoeopathic drugs. It is mandatory for the manufacturers to adhere to the
prescribed requirements of Good Manufacturing Practices (GMP) including proof of safety &
effectiveness as per Schedule T & Schedule M-I of Drugs Rules, 1945 and quality standards
of drugs given in the respective pharmacopoeia.
1Ministry of Ayush, Government of India has established Pharmacopoeia
Commission for Indian Medicine & Homoeopathy (PCIM&H) as its subordinate office.
PCIM&H lays down the formulary specifications and pharmacopoeial standards for
Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) drugs which serves as official
compendia for ascertaining the quality (identity, purity and strength) of the ASU&H drugs.
As per the Drugs & Cosmetics Act, 1940 and rules thereunder, the compliance to these
quality standards are mandatory for the production of ASU&H drugs being manufactured in
India. So far, 2269 quality standards on raw materials (single drugs of plant/ animal/
mineral/ metal/ chemical origin) used in ASU&H drugs, 426 quality standards of ASU
formulations and 2799 formulary specifications of ASU drugs has been published. In
addition to above, supporting documents in the form of Macro-Microscopic & Thin-layer
chromatography (TLC) Atlas on 392 single drugs incorporated in Ayurvedic
Pharmacopoeia of India (API) has also been published.
PCIM&H also acts as the Appellate Drugs testing Laboratory for testing or analysis
of ASU&H Drugs. In addition, it conducts capacity-building trainings at regular intervals
for the standardization, quality control, and testing or analysis of ASU&H drugs for Drug
Regulatory Authorities, Drug Analysts, and other relevant stakeholders, with a focus on
laboratory techniques and methodologies essential for ensuring the quality of ASU&H
drugs.
Rule 160 A to J of the Drugs Rules, 1945 provides the regulatory guidelines for
approval of Drug Testing Laboratory for carrying out tests of identity, purity, quality and
strength of Ayurvedic, Siddha, Sowa Rigpa and Unani drugs as may be required under the
provisions of these rules. As on date, 34 State/UTs Drug Testing Laboratories and 108
private laboratories are approved or licensed under the provisions of Drugs Rules, 1945 for
quality testing of Ayurvedic, Siddha, Sowa Rigpa and Unani drugs and raw materials.
As per the information received from states/UTs Governments including Bihar, the
details of the mechanism to address the issue of standardization and quality control of
Ayush medicines and products in the country along with the efforts to improve the quality
of Ayush medicines/products are attached at Annexure.
(d) Ministry of Ayush has established Central Councils for Research in Ayurveda, Yoga &
Naturopathy, Unani, Siddha & Homoeopathy as apex organizations for undertaking,
coordinating, formulating, developing and promoting research in Ayush systems on
scientific lines. Core Research activities comprise of Medicinal Plant Research (Medico-
Ethno Botanical Survey, Pharmacognosy and in vitro-propagation technique), Drug
Standardization, Pharmacological Research, Clinical Research, Literary Research &
Documentation and Tribal Health Care Research Programme. Research activities are carried
out through its peripheral Institutes/Units located across the country and in collaboration
with various Universities, Hospitals and Institutes.
Further, the Ministry of Ayush is implementing the Central Sector Scheme namely
AYURGYAN Scheme from FY 2021-22. The Scheme has 03 components viz. (i) Capacity
Building & Continuing Medical Education (CME) in Ayush (ii) Research & Innovation in
Ayush from the FY 2021-22 and iii) Ayurveda Biology Integrated Health Research is also
added under the scheme from FY 2023-24. Under the Research & Innovation in Ayush and
Ayurveda Biology Integrated Health Research component, financial assistance is being
2provided to the Organizations/Institutions for research studies, for promotion of research in
Ayush system.
The Ministry of Ayush is implementing the central sector scheme for Promotion of
International Cooperation for Ayush (IC Scheme). Under this scheme, Ministry provides
support to Indian Ayush drug Manufacturers/ Ayush Service providers to give boost to the
export of Ayush products and services, facilitates the International promotion, development
and recognition of Ayush systems of medicine, foster interaction of stakeholders and market
development of Ayush at international level, promote academics and research through the
establishment of Ayush Academic Chairs in foreign countries and holding training
workshop/symposiums for promoting and strengthening awareness and interest about Ayush
Systems of Medicine at international level.
Under this IC Scheme, 25 Country-to-Country MoUs, 15 Ayush Chair MoUs and 52
Institute-to-Institute level MoUs have been signed.
(e) Ministry of Ayush has implemented Central Sector Scheme Ayush Oushadhi Gunvatta
Evam Uttpadan Samvardhan Yojana (AOGUSY). The total financial allocation to this
scheme is Rs. 122.00 crores for five years. The components of AOGUSY scheme are as
follows -
A. Strengthening and up-gradation of Ayush Pharmacies and Drug Testing Laboratories to
achieve higher standards.
B. Pharmacovigilance of ASU&H drugs including surveillance of misleading advertisements.
C. Strengthening of Central and State regulatory frameworks including Technical Human
Resource & Capacity Building programs for Ayush drugs.
D. Support for development of standards and accreditation/certification of Ayush products &
materials in collaboration with Bureau of Indian Standards (BIS), Quality Control of India
(QCI) and other relevant scientific institutions and industrial R&D centres. Detailed
guidelines of AOGUSY scheme are available at
https://ayush.gov.in/images/Schemes/aoushdhi.pdf.
Further Ministry of Ayush encourages following certifications of Ayush products as
per details below: -
• The scheme for Certification of Pharmaceutical Product (CoPP) as per World Health
Organization (WHO) guidelines is extended to Ayurvedic, Siddha and Unani (ASU)
medicines. This scheme is administered by Central Drugs Standard Control Organization
(CDSCO) and the certificate is granted on the basis of joint inspection of the applicant
manufacturing unit by the representatives of CDSCO, Ministry of Ayush and the concerned
State Licensing Authority.
• Quality Certifications Scheme is implemented by the Quality Council of India (QCI) for
grant of Ayush mark viz. Ayush standard and Ayush premium marks to Ayurvedic, Siddha
and Unani products on the basis of third party evaluation of quality in accordance with the
status of compliance to GMP and WHO-GMP standards, respectively.
*******
3Annexure
As per the information received from states/UTs Governments including Bihar, the details of
the mechanism to address the issue of standardization and quality control of Ayush medicines
and products in the country along with the efforts to improve the quality of Ayush
medicines/products are as follows:
S. No. Name of the State/ UT Details
1. Uttarakhand State government nominated 14 Drug Inspectors in the
State to check the quality and production of Ayurvedic
& Unani medicines.
There are 07 Drug testing laboratories (DTLs) are
working in Uttarakhand in which 01 Government and 06
drug testing laboratories are approved by Ministry of
Ayush in Private sector are sanctioned under Drug &
Cosmetic Act 1940, Ruls1945 under rule 160A to 160J,
for checking the quality of Ayurvedic & Unani
medicines.
Uttarakhand Ayurvedic University
nominated as peripheral pharmacovigilance Centre for
compiling and reporting of adverse drug reaction
(ADR).
All manufacturing Units are GMP certified, the
respective District’s Drug Inspectors regularly do
inspection, and Sampling for testing.
2. Madhya Pradesh Madhya Pradesh have 01 state DTL and 07 Private
DTLs for testing of Ayush medicine.
In addition, 51 Drug Inspectors are notified in state for
Ayush medicine. In addition 07 pharmacovigilance
centers are working as monitoring system.
3. Delhi Routine inspections and lifting of survey samples are
undertaken as part of regular enforcement activities to
improve the quality of Ayush medicines/products.
4. Puducherry ISM Expert Committee is Constituted in UT of
Puducherry. Products were verified, evaluated and
approved by ISM Expert Committee.
Based on the recommendations from ISM Expert
Committee, necessary product approval is issued.
Product approvals are issued as per the rules 158(B) (II)
A read with Chapter IVA of Drugs and Cosmetics Act
1940 & Rules 1945.
Regular monitoring and Inspection is carried out by the
Drugs Inspectors, Department of Drugs
Control, Puducherry.
45. Ladakh In UT Ladakh the Sowa Rigpa medicine suppliers are
directed to ensure date of manufacturing and date of
expiry on label.
6. Kerala The Government of Kerala has constituted an expert
committee for the standardization of Ayurveda, Siddha,
Unani Drugs. The committee had submitted a
comprehensive draft report with recommendation for
implementation of various steps to improve the quality
of Ayurveda, Siddha, Unani Drugs.
7. Tripura A State DTL has been established to test Ayush drugs
for quality, purity, and strength. A central sector scheme
(AOGUSY) implemented to provide financial assistance
to drug testing laboratory to achieve higher standards.
Drug inspectors conduct regular inspections of the
market and draw samples for quality checking
8. Haryana A State Ayurvedic Drug Testing Laboratory is
functional in Haryana State. Moreover, 12 Private Drug
Testing Laboratories are also granted licence for testing
of ASU drugs/medicines under rule 160 B of Drug and
Cosmetic Rules-1945.
9. Arunachal Pradesh State Drug Testing Laboratory (Ayush) and Govt.
Ayurvedic Pharmacy are established in Arunachal
Pradesh for quality control of Ayush Drugs.
10. Uttar Pradesh For testing/analysis, the State Government operates 01
Drug Testing Laboratory with 01 State Government
Analyst, Ayurveda & Unani Medicine, Uttar Pradesh,
and 04 Private Drug Testing Laboratories certified by
the State Government under rule 160 A to J of the Drug
and Cosmetics Act- 1945.
One Pharmacovigilance Centre situated at Central
Research Institute of Unani Medicine, Lucknow, Uttar
Pradesh and 60 Drug Inspector Appoint in Uttar Pradesh
Including Ayurveda and Unani Department.
11. Bihar The Drugs Control Administration, Department of
Health, Bihar continuously monitor the Quality of drugs
(Ayush) by performing sampling & testing of the
marketed drugs in the state through its inspectorate staff.
State Govt. has also notified government Analyst and
Drugs Testing Laboratory, Agamkuan, Patna for the test
and Analysis of Ayurvedic, Unani and Homoeopathic
Medicines.
12. Odisha One State Drugs Testing and Research Laboratory
(ISM), Bhubaneswar is functioning in the State to
address the issue of standardisation and quality control
5of AYUSH medicines and products in the State.
13. Maharashtra Nil
14. Lakshadweep Nil
15. Gujrat Nil
16. West Bengal Nil
6